Agency Business briefs: September 2012

Share this article:
Reyn Archer
Reyn Archer

Miami-based JeffreyGroup won a com­petitive pitch to lead a Pfizer public health campaign in Latin America, PR Week reported. The unbranded effort is set to launch in the fall.

The Core Nation said agencies Brandkarma and Core-Create merged under the Brandkarma banner. The Core-Create name is gone, in favor of the name of the younger office, started five years ago.

Johnson & Johnson is consolidating ad creative, Ad Age reported. The review follows Michael Sneed's January appointment as VP corporate affairs, and Alex Gorsky's installment as CEO in April.

PR firm Burson-Marsteller launched a healthcare subsidiary, Consitor, with offices in Zurich and Washington, DC. Dr. Reyn Archer, managing director and chief medical officer in the Burson's US healthcare practice, will lead the DC office. Services include strategy development, brand life cycle management, KOL development, scientific communications, health economics, policy, advocacy and market access.

HCB Health was named agency of record for Austin-based Sanova Dermatology, a provider of medical, surgical and cosmetic skin care.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.